MK
Muthukumar Kala
About Muthukumar Kala
Data last updated:
Muthukumar Kala is a Director at Latin Labs Private Limited (since 2012) and Director at Maleo Pharma Private Limited (since 2015). The companies operate in Pharma and Trading. The 2 current companies with reported revenue have a combined latest revenue of ₹5.18 Cr; the largest is Latin Labs Private Limited at ₹5.00 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Latin Labs Private Limited U85100TN2012PTC085924 | Director | 16 May 2012 | 2012 | ₹5.00 Cr (FY 2024) | Active |
| Maleo Pharma Private Limited U24233TN2015PTC098679 | Director | 09 Jan 2015 | 2015 | ₹18.6 Lakh (FY 2025) | Active |
Board colleagues of Muthukumar Kala
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Muthukumar Kala
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Muthukumar Kala
Muthukumar Kala currently holds 2 directorships: Latin Labs Private Limited (Director, since 16 May 2012, revenue ₹5.00 Cr (FY 2024)); Maleo Pharma Private Limited (Director, since 09 Jan 2015, revenue ₹18.6 Lakh (FY 2025)).
Muthukumar Kala was first appointed on 16 May 2012 as Director at Latin Labs Private Limited. The most recent appointment on record is 09 Jan 2015 at Maleo Pharma Private Limited.
The 2 current companies of Muthukumar Kala that report revenue have a combined latest revenue of ₹5.18 Cr: Latin Labs Private Limited ₹5.00 Cr (FY 2024); Maleo Pharma Private Limited ₹18.6 Lakh (FY 2025).
The current boards of Muthukumar Kala's companies include Anandha Krishnan Venkatraman (Latin Labs Private Limited), Anbarasan Puvimathi (Latin Labs Private Limited), Bhuvaneswari (Latin Labs Private Limited), Dhamodharan (Latin Labs Private Limited), Dhanasekar (Latin Labs Private Limited), Ganapathy Rajaraman (Latin Labs Private Limited), among others.